In good agreement, CHI3L1 suppression by shRNA reduced glioma cell invasion, anchorage-independent growth and increased cell death in response to several anticancer drugs, including cisplatin, etoposide and doxorubicin [23]. Here, CHI3L1 is linked to central nervous system cancer.